QIAGEN Launches QIAsure Methylation Test to Determine Cervical Cancer Risk
Go back to QIAGEN Launches QIAsure Methylation Test to Determine Cervical Cancer Risk| Qiagen NV (NYSE: QGEN) | Delayed: 44.07 -0.83 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.90 | 52 Week High | $28.50 | |||
| Open | $44.39 | 52 Week Low | $19.94 | |||
| Day High | $44.47 | P/E | 151.97 | |||
| Day Low | $43.78 | EPS | $0.29 | |||
| Volume | 3,304,173 | |||||
| (NYSE: QIA) | Delayed: 0.00 -10.35 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.35 | 52 Week High | $ | |||
| Open | $10.35 | 52 Week Low | $ | |||
| Day High | $10.35 | P/E | N/A | |||
| Day Low | $10.35 | EPS | $ | |||
| Volume | 0 | |||||
